Amedeo Smart

Free Medical Literature Service


 

Amedeo

Tuberculosis

  Free Subscription

05.10.2026

1 Clin Infect Dis
1 Eur J Clin Microbiol Infect Dis
5 Int J Tuberc Lung Dis
1 J Infect Dis



    Clin Infect Dis


  1. Correction to: The Xpert MTB/RIF Cycle Threshold Value Predicts Mycobacterium tuberculosis Transmission to Close Contacts in a Brazilian Prospective Multicenter Cohort.
    Clin Infect Dis. 2026 Sep 30:ciag589. doi: 10.1093.
    >> Share


    Eur J Clin Microbiol Infect Dis

  2. LI XJ, Zhang N, Zhang Q, Chen R, et al
    HBV/HCV coinfection and anti-tuberculosis drug-induced liver injury: from risk assessment and exploration of mechanisms to preventive considerations.
    Eur J Clin Microbiol Infect Dis. 2026 Sep 29. doi: 10.1007/s10096-026-05686.
    >> Share


    Int J Tuberc Lung Dis

  3. BELLAVIA A, Refera TA, Silva DR, Kherabi Y, et al
    Results of the FAST-TB end-users' survey align with priority research questions on new TB treatment regimens.
    Int J Tuberc Lung Dis. 2026;30:427-435.
    >> Share

  4. GOSHU EM, Woldegiorgis AG, Dememew ZG, Gebremedihin ED, et al
    Unmasking isoniazid resistance in rifampicin-susceptible TB: a national multicentre study using Xpert MTB/XDR.
    Int J Tuberc Lung Dis. 2026;30:442-447.
    >> Share

  5. HABIB MA, Efa SS, Afrin K, Islam N, et al
    Diabetes prevalence and factors associated with newly detected diabetes in elderly TB patients.
    Int J Tuberc Lung Dis. 2026;30:454-459.
    >> Share

  6. MGEYI EN, Swai CA, Luge PA, Kavishe I, et al
    Improving childhood TB case notification through intensified clinical services.
    Int J Tuberc Lung Dis. 2026;30:436-441.
    >> Share

  7. ZANGPO T, Norbu T, Tenzin P, Nima G, et al
    Factors associated with primary rifampicin-resistant/multidrug-resistant TB: a case-control study.
    Int J Tuberc Lung Dis. 2026;30:448-453.
    >> Share


    J Infect Dis

  8. ALKHAFAJI S, Yang E, Lee K, Chang VK, et al
    Ethambutol Population Pharmacokinetics and Pharmacodynamics From a Phase 3 Confirmatory Trial for the Treatment of Tuberculosis.
    J Infect Dis. 2026 Sep 30:jiag431. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016